Caris Life Sciences (CAI) Long-Term Debt Issuances (2024 - 2025)
Caris Life Sciences has reported Long-Term Debt Issuances over the past 2 years, most recently at -$27.9 million for Q3 2025.
- Quarterly results put Long-Term Debt Issuances at -$27.9 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $172.1 million (changed N/A YoY), and the annual figure for FY2024 was $200.0 million, changed.
- Long-Term Debt Issuances for Q3 2025 was -$27.9 million at Caris Life Sciences, down from $200.0 million in the prior quarter.
- Over the last five years, Long-Term Debt Issuances for CAI hit a ceiling of $200.0 million in Q4 2024 and a floor of -$27.9 million in Q3 2025.